Hanseatic Management Services’s Acadia Pharmaceuticals ACAD Stock Holding History

Hanseatic Management Services’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-266	Closed	-$13K	–	178
2020 Q2	$13K	Hold	266	–	–	0.01%	138
2020 Q1	$11K	Hold	266	–	–	0.01%	152
2019 Q4	$11K	Buy	+266	New	+$11.6K	0.01%	187
2016 Q4	–	Sell	-29	Closed	-$1K	–	311
2016 Q3	$1K	Sell	29 -30,996	-100%	-$1.05M	﹤0.01%	264
2016 Q2	$1.01M	Buy	+31,025	New	+$1.04M	0.38%	88

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

PAMU

Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return

Hanseatic Management Services's ACAD Position: Q3 2020 in Review

Hanseatic Management Services sold out of Acadia Pharmaceuticals (ACAD) in Q3 2020, closing a stake of 266 shares — an estimated $13K sold.

Hanseatic Management Services first reported a position in ACAD in Q2 2016 and held it in 5 quarters. The position peaked at $1.01M in Q2 2016. 267 funds tracked by Wall St. Rank hold ACAD as of Q3 2020.

Hanseatic Management Services reported no remaining Acadia Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
Hanseatic Management Services sold 266 Acadia Pharmaceuticals shares in Q3 2020, an estimated $13K.
Hanseatic Management Services first reported a position in Acadia Pharmaceuticals in Q2 2016 and held it in 5 quarters.
Hanseatic Management Services's Acadia Pharmaceuticals position peaked at $1.01M in Q2 2016.
267 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2020.

Based on Hanseatic Management Services's 13F filing for Q3 2020, filed 29 Oct 2020.